20 articles
UC Berkeley researchers discovered brain circuits linking deep sleep to growth hormone release, revealing how sleep builds muscle and burns fat.
Clinical trial shows solriamfetol significantly improves alertness and performance in workers who start before sunrise.
New NIH research reveals the brain-cell signaling mechanism behind GLP-1 drug plateaus and a potential way to extend their effects.
A study of 100,000 people found semaglutide users had 44% lower depression risk and 42% fewer psychiatric hospitalizations.
Early-life exposure to DEHP, a plasticizer in everyday products, caused lasting anxiety in male rats — and GABA or testosterone reversed it.
New research reveals GLP-1 drugs like Ozempic significantly reduce depression, anxiety, and substance use disorders alongside weight management.
A home-based walking and resistance program improved attention and reduced observable cognitive decline in chemotherapy patients over 6 weeks.
Declining Menin in the hypothalamus drives inflammation and aging. Restoring it reversed decline; D-serine amino acid improved cognition in mice.
New research suggests AI-powered therapy may deliver better mental health outcomes than traditional human-delivered care.
High-dose niacin revived suppressed immune cells in glioblastoma patients, with 82% showing no progression at 6 months — 28% better than expected.
A molecule called OLE restores microglia's protective function, reducing amyloid plaques and improving memory in animal models.
A 12-week clinical trial found older adults taking probiotics with antidepressants had greater reductions in depression and anxiety than placebo.
New brain-targeted gene therapy mimics morphine's pain relief while avoiding addiction, offering hope for 50+ million Americans with chronic pain.
Researchers created modified psilocin that maintains antidepressant effects while dramatically reducing psychedelic side effects in mice.
Scientists discover brain support cells help glioblastoma grow and identify existing HIV drug that could disrupt this deadly communication.
Norwegian researchers say short bursts of high-intensity effort just 4.5 minutes daily dramatically improve cardiovascular fitness and lifespan.
Comprehensive analysis reveals whole dietary patterns, not individual supplements, show strongest links to reduced depression in adolescents.
Scientists identify how nitric oxide triggers cellular changes in autism, offering hope for targeted therapies.
Three existing drugs, including a shingles vaccine, emerge as top candidates for repurposing against Alzheimer's disease.
Researchers turned ordinary brain cells into plaque-clearing machines, reducing Alzheimer's amyloid by half in mice with one treatment.
